oxaprozin has been researched along with Porphyrias in 2 studies
Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis.
Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report two cases of pseudoporphyria caused by naproxen and oxaprozin." | 4.80 | Pseudoporphyria induced by propionic acid derivatives. ( Al-Khenaizan, S; Sasseville, D; Schechter, JF, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ingrish, G | 1 |
| Rietschel, RL | 1 |
| Al-Khenaizan, S | 1 |
| Schechter, JF | 1 |
| Sasseville, D | 1 |
1 review available for oxaprozin and Porphyrias
| Article | Year |
|---|---|
Pseudoporphyria induced by propionic acid derivatives.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Drug Eruptions; Female; Humans; | 1999 |
1 other study available for oxaprozin and Porphyrias
| Article | Year |
|---|---|
Oxaprozin-induced pseudoporphyria.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Drug Eruptions; Humans; Male; Midd | 1996 |